Comparative molecular docking and simulation analysis of molnupiravir and remdesivir with SARS-CoV-2 RNA dependent RNA polymerase (RdRp)

被引:0
|
作者
Patil, Shashank M. [1 ]
Maruthi, K. R. [2 ]
Bajpe, Shrisha Naik [2 ]
Vyshali, V. M. [3 ]
Sushmitha, S. [3 ]
Akhila, Chagalamari [4 ]
Ramu, Ramith [1 ]
机构
[1] JSS Acad Higher Educ & Res, Sch Life Sci, Dept Biotechnol & Bioinformat, Mysuru 570015, Karnataka, India
[2] Sri Dharmasthala Manjunatheshwara Coll Autonomous, Dept Biotechnol, Ujire 574240, Karnataka, India
[3] BMS Coll Women, Dept Biotechnol, Bengaluru 560004, Karnataka, India
[4] JSS Acad Higher Educ & Res, JSS Med Coll, Dept Pharmacol, Mysuru 570015, Karnataka, India
关键词
SARS-CoV-2; RdRp; Molnupiravir; Remdesivir; in silico experiments; molecular docking; molecular dynamics; binding free energy calculations; druglikeliness and pharmacokinetic properties;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Treatment of SARS-CoV-2 targeting its RNA dependent RNA polymerase (RdRp) is of current interest. Remdesivir has been approved for the treatment of COVID-19 around the world. However, the drug has been linked with pharmacological limitations like adverse effects and reduced efficiency. Nevertheless, recent advancements have depicted molnupiravir as an effective therapeutic agent to target the SARS-CoV-2 RdRp. The drug has cleared both in vitro and in vivo screening. It is in phase-III clinical trial. Nonetheless, there are no data on themolecular binding interaction of molnupiravir with RdRp. Therefore, it is of interest to report the binding interaction of molnupiravir using molecular docking. It is also of interest to show its stability during interaction using molecular dynamics and binding free energy calculations along with drug likeliness and pharmacokinetic properties in comparison with remdesivir.
引用
收藏
页码:932 / 939
页数:8
相关论文
共 50 条
  • [1] Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
    Elfiky, Abdo A.
    [J]. LIFE SCIENCES, 2020, 253
  • [2] Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2
    Arba, Muhammad
    Wahyudi, Setyanto Tri
    Brunt, Dylan J.
    Paradis, Nicholas
    Wu, Chun
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 129
  • [3] Molecular docking analysis of SARS-CoV-2 linked RNA dependent RNA polymerase (RdRp) with compounds from Plectranthus amboinicus
    Selvaraj, Jayaraman
    Rekha, Umapathy Vidhya
    Fathima, Shazia J. H.
    Sivabalan, Venkatacalam
    Ponnulakshmi, Rajagopal
    Vishnupriya, Veeraraghavan
    Kullappan, Malathi
    Sreekandan, Radhika Nalinakumari
    Mohan, Surapaneni Krishna
    [J]. BIOINFORMATION, 2021, 17 (01) : 167 - +
  • [4] Evaluation of molnupiravir analogues as novel coronavirus (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors - an in silico docking and ADMET simulation study
    Kulabas, Necla
    Yesil, Tugce
    Kucukguzel, Ilkay
    [J]. JOURNAL OF RESEARCH IN PHARMACY, 2021, 25 (06): : 967 - 981
  • [5] Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study
    Wakchaure, Padmaja D.
    Ghosh, Shibaji
    Ganguly, Bishwajit
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2020, 124 (47): : 10641 - 10652
  • [6] SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
    Elfiky, Abdo A.
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09): : 3204 - 3212
  • [7] Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
    Bibi, Shabana
    Hasan, Mohammad Mehedi
    Wang, Yuan-Bing
    Papadakos, Stavros P.
    Yu, Hong
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (01) : 152 - 162
  • [8] SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study
    Ahmad, Jamshaid
    Ikram, Saima
    Ahmad, Fawad
    Rehman, Irshad Ur
    Mushtaq, Maryam
    [J]. HELIYON, 2020, 6 (07)
  • [9] Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
    Wu, Yifei
    Crich, David
    Pegan, Scott D.
    Lou, Lei
    Hansen, Madelyn C.
    Booth, Carson
    Desrochers, Ellison
    Mullininx, Lauren Nicole
    Starling, Edward B.
    Chang, Kuan Y.
    Xie, Zhong-Ru
    [J]. MOLECULES, 2021, 26 (24):
  • [10] Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase
    Ahmed, Sinthyia
    Mahtarin, Rumana
    Islam, Md Shamiul
    Das, Susmita
    Al Mamun, Abdulla
    Ahmed, Sayeda Samina
    Ali, Md Ackas
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21): : 11111 - 11124